DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,160 filers reported holding DANAHER CORPORATION in Q1 2024. The put-call ratio across all filers is 1.13 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,793 | +0.1% | 7,178 | 0.0% | 0.19% | +7.8% |
| Q1 2024 | $1,792 | +7.2% | 7,178 | -0.6% | 0.18% | -17.1% |
| Q4 2023 | $1,671 | -22.5% | 7,223 | -16.9% | 0.22% | -30.9% |
| Q3 2023 | $2,157 | +4.8% | 8,693 | +1.4% | 0.31% | -18.7% |
| Q2 2023 | $2,059 | -1.7% | 8,577 | +3.2% | 0.39% | -11.1% |
| Q1 2023 | $2,094 | -99.9% | 8,308 | +6.8% | 0.43% | -12.9% |
| Q4 2022 | $2,065,427 | -17.4% | 7,782 | -19.6% | 0.50% | -25.1% |
| Q3 2022 | $2,501,000 | +1.9% | 9,682 | +0.0% | 0.66% | +6.1% |
| Q2 2022 | $2,454,000 | -8.9% | 9,681 | +5.4% | 0.63% | +4.5% |
| Q1 2022 | $2,693,000 | -13.9% | 9,181 | -3.4% | 0.60% | -10.2% |
| Q4 2021 | $3,129,000 | +23.7% | 9,509 | +14.4% | 0.67% | +15.4% |
| Q3 2021 | $2,530,000 | +18.1% | 8,309 | +4.1% | 0.58% | +18.2% |
| Q2 2021 | $2,142,000 | +18.5% | 7,981 | -0.6% | 0.49% | +9.6% |
| Q1 2021 | $1,808,000 | +47.1% | 8,031 | +45.2% | 0.45% | +46.1% |
| Q4 2020 | $1,229,000 | -16.9% | 5,531 | -19.4% | 0.31% | -4.1% |
| Q3 2020 | $1,479,000 | +21.2% | 6,866 | -0.5% | 0.32% | +16.8% |
| Q2 2020 | $1,220,000 | +5.4% | 6,900 | -17.5% | 0.27% | -17.0% |
| Q1 2020 | $1,157,000 | -12.0% | 8,361 | -2.5% | 0.33% | +9.3% |
| Q4 2019 | $1,315,000 | -1.1% | 8,571 | -6.8% | 0.30% | -22.4% |
| Q3 2019 | $1,329,000 | +0.5% | 9,200 | -0.5% | 0.39% | +4.3% |
| Q2 2019 | $1,322,000 | +8.3% | 9,250 | +0.0% | 0.37% | -0.8% |
| Q1 2019 | $1,221,000 | – | 9,249 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |